HOME >> MEDICINE >> NEWS
Diabetes drug improves metabolic changes associated with HIV combination therapy

Use of an oral antidiabetes medication produced significant improvement in a group of patients with HIV lipodsytrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection. In the May 18 Annals of Internal Medicine, researchers from Massachusetts General Hospital (MGH) report that daily doses of rosiglitazone (Avandia) improved insulin sensitivity and alleviated fat redistribution in patients with lipodystrophy and insulin resistance.

The drug combination strategy known as highly active antiretrovial therapy (HAART) can significantly reduce viral levels and help maintain health in HIV-infected individuals, but a significant number can develop lipodystrophy. Typical symptoms of the syndrome may include a loss of subcutaneous fat in the face, arms, and legs; increased fat deposits in the abdomen and upper back; changes in cholesterol and other blood lipids; and insulin resistance.

"The metabolic complications of this condition are becoming more significant as patients spend more time on HAART," says Colleen Hadigan, MD, MPH, of the MGH Neuroendocrine Unit and Program in Nutritional Metabolism, the report's lead author. "For example, we now know that 14 percent of men on this therapy may develop type 2 diabetes, which is four times the usual risk; and concerns are also increasing about the related risk of heart disease."

Although previous studies have examined the effect of rosiglitazone and similar medications on HIV lipodystrophy, the results have been inconclusive. Since patients with the syndrome may have a variety of associated symptoms, the current study was limited to participants who had developed insulin resistance. The 27 enrolled patients were randomized to receive daily doses of either rosiglitazone or a placebo, and neither participants nor the researchers knew who was receiving the active medication.

At the end of the three-month
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
17-May-2004


Page: 1 2

Related medicine news :

1. Diabetes a bigger heart disease risk for women than for men
2. Diabetes: A link between oral and overall health?
3. Diabetes among older adults imposed an estimated $133.5 billion cost in 1990s
4. Diabetes increases deaths among people 65 and older
5. Diabetes may be going unnoticed in many UK children
6. Diabetes linked to increased risk of Alzheimers in long-term study
7. Diabetes patients skip medications to save money
8. Diabetes doubles risk of liver disease and liver cancer
9. Salk news: Diabetes first steps
10. Diabetes management improves when patients, doctors agree on treatment goals, UMHS study finds
11. Diabetes patients with low literacy more likely to have poorly controlled disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology:
Cached News: